Ectodermal dysplasias are a group of genetic disorders defined by ectodermal derivative impairment (EDI). To test the impact of the Wnt/beta-catenin pathway in the genetic screening of EDI, we performed a molecular gene study of WNT10A in 60 subjects from a population of 133 young Italian patients referred for the impairment of at least one major ectodermal-derived structure and who had a previous negative molecular screen for ectodysplasin signaling pathway genes ED1, EDAR, and EDARADD. Fourteen WNT10A mutations were identified in 33 subjects (24.8%), 11 of which were novel variants. The phenotype was evaluated through a detailed clinical examination of the major and minor ectodermal-derived structures. This study is the first to show that, after ED1, WNT10A is the second molecular candidate for EDI in a large Italian Caucasian population. The study confirmed that Phe228Ile is the most frequent WNT10A variant in Caucasian populations, and that WNT10A mutations are associated with large variability in EDI.
pathway genes, to carefully evaluate the phenotypic heterogeneity of subjects carrying WNT10A mutations, and to investigate their potential genotype-phenotype correlations.
| MATERIALS AND METHODS
Sixty subjects from a population of 133 Italian Caucasian patients aged 2-25 years presenting with impairment of at least one ectodermal derivative who tested negative in previous molecular screening for EDA, EDAR, and EDARADD were studied for WNT10A mutations.
Parents of WNT10A-positive subjects have been tested to define the segregation.
Written informed consent was obtained from subjects or, in the case of minors, from their parents. The study was approved by the When a sequence variant was not previously associated with an ED phenotype, it was considered disease-causing only when linked to an EDI in the proband's family.
All subjects included in the study were evaluated by a multidisciplinary medical team consisting of a dentist, dermatologist, ophthalmologist, and otolaryngologist in order to assess the presence and degree of clinical signs related to the disease. The phenotype was described by a detailed clinical examination of ectodermal-derived structures and the manifestation scored as 0 (absent), 1 (mild), or 2 (severe) ( Table 1) .
| RESULTS
ED1 mutations were present in 45% of subjects in the whole population of EDI patients, WNT10A mutations in 25%, EDAR mutations in 7.5%, and EDARADD in 1.5%. The data on phenotype and genotype are reported in Tables 1 and 2 , respectively.
Among the 60 subjects studied for WNT10A, sequence variants were identified in 33 (55%). Fourteen different mutations were found, including 11 novel variants. Six of the novel variants were present in a compound heterozygous state and five were heterozygous mutations. Two of the mono-allelic novel mutations were not considered disease-causing and not included in the discussion (28 and 30). Bi-allelic WNT10A mutations were found in 20 subjects (60.6%), whereas the remaining 13 subjects carried mono-allelic mutations.
The most common mutation found in our population was 682T>A (p.Phe228Ile), which reported in 24 subjects: 8 (33.3%)
homozygous and 16 (66.6%) heterozygous. All subjects carrying this a Dentition was assessed by panoramic radiographs from the age of 3 years. Hypodontia (1) was defined as agenesis of less than six teeth and oligodontia (2) as agenesis of six or more. #Panoramic radiograph not performed.
b Abnormal morphology of the dental crown was described as the presence of two or fewer conoid elements (1) or more than two conoid teeth (2).
c Sweating was studied using the standard starch-jodine method on the palms. We defined moderate dysfunction (1) as the number of pores in a square centimeter being 20-70% of normal and severe dysfunction (2) as the number of pores being <20%.
d Moderate involvement of the skin (1) was defined as the presence of light and thin skin. Severe skin involvement (2) was defined as a visible venous pattern, xerosis, and periorbital hyperpigmentation.
e Moderate onychodystrophy (1) was considered when thin and fragile nails were present, and severe onychodystrophy (2) when micronychia and reduced growth were present.
f Moderate impairment of hair (1) was defined as the presence of thin and slightly sparse hair and severe impairment (2) as the presence of partial or total alopecia. *Absence of beard.
g Meibomian gland function and ocular surface dryness were studied using the tear break-up time (TBUT) test. A normal level of dry eye (0) was defined as a TBUT >10 s, and pathological dry eye (2) as a TBUT <10 s.
h Moderate involvement of the respiratory tract (1) was defined as the patient suffering more than six upper respiratory tract infections (URTIs) per year, and severe involvement (2) as the patient suffering from at least three lower respiratory tract infections (LRTIs) per year.
i Hearing function was assessed by otomicroscopy, audiometry, and tympanometry. Normal auditory function (0) was reported when the hearing threshold was <20 dB. Deafness was defined as mild (1) when the hearing threshold was between 20 and 40 dB, or moderate to severe (2) when the hearing threshold was >40 dB. Fifty-five percent of homozygous and 38% of heterozygous subjects presented with the involvement of at least two major ectodermal derivatives. Two compound heterozygous subjects presented with impairment of all three major ectodermal derivatives.
Dental abnormalities (number and/or shape) were present in 87.1% of the subjects: 61.3% had oligodontia and 16.6% hypodontia.
Abnormal crown morphology was described in 13 subjects (41.9%); in three of them, all carrying bi-allelic mutations, it was the only dental anomaly. Four subjects, all carrying mono-allelic mutations, had no dental abnormalities.
Impairment of hair was detectable in 38.7% of the subjects; one (number 24). presented complete alopecia as the only clinical sign.
Sweating dysfunction was present in 32.3% of the subjects: 29% with a mild reduction in sweating ability and 3.3% presenting with complete anhidrosis.
Onychodystrophy and skin abnormalities were described in 41.9%, and dry eyes in 29% of the subjects.
Frequent infections of the respiratory tract were found in 30% of the subjects. Mild grade sensorineural deafness was reported in three subjects.
| DISCUSSION
Our study shows that WNT10A is the second most common molecular candidate for EDI in an Italian Caucasian cohort, confirming the results of previous studies in patients of other nationalities. [3] [4] [5] In particular, 25% of our patients carried a potentially disease-causing mutation in the WNT10A gene. This percentage is similar to that found by Cluzeau et al 3 in a population selected using the same clinical criteria. As expected, the percentage of WNT10A mutations was significantly lower than in populations selected on the basis of oligodontia. 7, 9 Previous studies associated WNT10A mutations with a broad spectrum of different pathological conditions, ranging from the most recurrent isolated tooth agenesis 8,10,11 to complex but rare phenotypes, such as OODD 5 and SSPS. 12 More recently, some authors described WNT10A-linked oligo/hypodontia phenotypes associated with other EDIs, such as mild hair, nails, and sweating anomalies. 3 In their ED population study, Cluzeau et al 4 reported WNT10A mutations in patients with total anhidrosis or who did not have teeth involvement. 3 In line with these studies, our data show that WNT10A mutations can be associated with extensive variability of EDIs, ranging from isolated oligodontia to impairment of all other ectodermal derivatives.
For example, we described complete anhidrosis in one subject and complete alopecia in another subject. Two compound heterozygous subjects presented with the involvement of all three major ectodermal derivatives together with severe onychodystrophy and dermatitis, presenting a clinical picture indistinguishable from that of ectodysplasin pathway gene deficiency.
Our data confirm that abnormalities in tooth number and/or shape is the most specific clinical sign related to WNT10A mutations; however, we found that teeth abnormalities may also be absent. In our population, dental anomalies were absent in four subjects, all heterozygous for WNT10A variants. Isolated dental agenesis was reported in four subjects, three of whom had a bi-allelic mutation and one a heterozygous Phe228Ile mutation.
In line with other studies, 3, 4 we did not identify a clear genotype/phenotype correlation in our WNT10A population, probably due to the small number of subjects carrying the same mutations, with the exception of the Phe228Ile variant. On the other hand, we did observe a positive correlation between bi-allelic mutations and clinical severity; 55% of the homozygous subjects presented with at least two major ectodermal derivatives compared to 36.3% of the heterozygous subjects (P < 0.05). None of the heterozygous subjects presented with involvement of all three major ectodermal derivatives.
The most recurrent WNT10A variants in previous studies were c.321C>A (p.Cys107) and c.682T>A (p.Phe228Ile). 4, 6, 7 In our population composed entirely of Italian Caucasian patients, the incidence of the Phe228Ile variant was 72.7% considering both mono-and biallelic variants. This finding is in line with the results of a frequency study conducted by Mues et al 7 showing that the prevalence of the Phe228Ile variant is significantly higher in Caucasian individuals.
We observed a possible autosomal-dominant inheritance of the Phe228Ile heterozygous variant. However, the presence of parents and siblings with a different degree of phenotypic expression, which has also been reported by previous authors, may suggest incomplete penetrance of this or other WNT10 variants. 4 In the genetic screening, the presence of tooth agenesis (isolated or associated with mild EDI) suggests studying WNT10A. However, the absence of tooth involvement or the presence of severe EDI does not exclude potentially disease-causing mutations in this gene. Moreover, our data suggest that a single ectodermal-derivative abnormality other than dental anomalies is sufficient for a subject to be a potential carrier of WNT10A mutations. Finally, patients presenting with dental anomalies in regards to number and/or shape or a documented WNT10A mutation should be examined carefully by an expert multidisciplinary medical team in order to investigate EDIs.
